Future investigations are warranted to explore the therapeutic potential of targeting this pathway in the management of DN, to conduct mechanistic studies validating the role of GAS6-DT in DN, and to confirm the predicted interactions with other biomolecules as suggested underlying mechanisms. Here, GAS6 is linked to liver dysplastic nodule.